{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:02:08Z","timestamp":1649116928875},"reference-count":21,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1590\/0037-8682-0156-2014","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T20:38:47Z","timestamp":1445459927000},"page":"507-513","source":"Crossref","is-referenced-by-count":4,"title":["Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence"],"prefix":"10.1590","volume":"48","author":[{"given":"J\u00falia Souza","family":"Vidal","sequence":"first","affiliation":[{"name":"Universidade de Bras\u00edlia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus Tolentino","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal do Amazonas,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro Niskier","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Universidade de Bras\u00edlia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1590\/S1806-37132012000400014","article-title":"Tuberculose, HIV e pobreza: tend\u00eancia temporal no Brasil, Am\u00e9ricas e mundo","volume":"38","author":"Guimar\u00e3es RM","year":"2012","journal-title":"J Bras Pneumol"},{"key":"ref2","series-title":"Biblioteca Virtual em Sa\u00fade - Consulta ao DeCS - Descritores em Ci\u00eancias da Sa\u00fade","year":"2014"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.5123\/S1679-49742012000400013","article-title":"Indica\u00e7\u00e3o da prova tubercul\u00ednica e infec\u00e7\u00e3o latente da tuberculose em HIV-positivos, Munic\u00edpio de Blumenau, Estado de Santa Catarina, Brasil, 2004-2009","volume":"21","author":"Siqueira KZ","year":"2012","journal-title":"Epidemiol Serv Saude"},{"key":"ref4","year":"2011"},{"key":"ref5","year":"2011"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0032-1333544","article-title":"Treatment of latent tuberculosis infection","volume":"34","author":"Vernon A","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"ref7","series-title":"Consulta a produtos - Medicamentos","year":"2003"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad AR","year":"1996","journal-title":"Control Clin Trials"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt G","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007545.pub2","article-title":"Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB","volume":"7","author":"Sharma SK","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson NA","year":"2011","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling TR","year":"2011","journal-title":"N Engl J Med"},{"key":"ref13","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref14","series-title":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health","year":"2013"},{"key":"ref15","series-title":"Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children","year":"2013"},{"key":"ref16","series-title":"British HIV Association guidelines for the treatment of TB\/HIV coinfection 2011","author":"Pozniak AL","year":"2011"},{"key":"ref17","series-title":"National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control","year":"2011"},{"key":"ref18","series-title":"Management of tuberculosis: a handbook for clinicians","author":"Street A","year":"2012"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.200512-1953OC","article-title":"Weekly rifapentine\/isoniazid or daily rifampin\/pyrazinamide for latent tuberculosis in household contacts","volume":"173","author":"Schechter M","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jclinepi.2014.02.001","article-title":"A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials","volume":"67","author":"Mathieu E","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000171.pub3","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo C","year":"2010","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v48n5\/1678-9849-rsbmt-48-05-00507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T03:52:41Z","timestamp":1495511561000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822015000500507&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0037-86822015000500507"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0156-2014","relation":{},"ISSN":["0037-8682"],"issn-type":[{"value":"0037-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}